A multi-omics framework integrating gut microbiota, blood metabolites, and immune cells to elucidate the pathogenesis of Alzheimer's disease.
Overview
- Naval Medical Centre, Naval Medical University, Shanghai, China
Abstract
Background: Alzheimer’s disease (AD) develops through complex interactions between the central nervous system and peripheral systems. The microbiota-metabolite-im
Methods: We used a multi-stage, multi-omics strategy to systematically investigate peripheral–central interactions in AD. The analytical framework integrated Mendelian randomization (MR), summary-data-based Mendelian randomization (SMR), differential expression analysis, machine learning, single-cell and spatial transcriptomics, and quantitative real-time polymerase chain reaction (qPCR) trend confirmation.
Results: Exploratory MR analyses identified multiple microbial taxa, metabolites, and immune cell phenotypes showing associations consistent with potential causal effects on AD. Integrating the SMR and MR findings with differential expression analysis led to the identification of 31 core genetically associated genes. A five-gene predictive model comprising ATF7IP2, TWSG1, PTPRN2, ASCC3 and IGF1R was then developed using machine learning. The diagnostic potential of the individual feature genes was further evaluated in an external validation dataset. Spatial transcriptomic analyses revealed clear cell type-specific expression patterns in brain tissue, with IGF1R, ASCC3and TWSG1 showing potential co-localization in oligodendrocytes. qPCR trend confirmation in pooled samples produced expression trends consistent with the directions inferred from eQTL-based MR.
Conclusions: This study mapped a regulatory network underlying the AD microbiota–metabolite-im
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- geo:GSE36980, at NCBI GEO; found in the text, “Data sources”
Other data links
- ncbi.nlm.nih.gov/
geo , NCBI; found in the text, “Data sources”
Data availability statement
The original contributions presented in the study are included in the article/
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, pages, dates, 3 authors, 5 keywords, 9 MeSH terms, 45 references.
Cite
This paper
Wang, B., Yan, W., & Zhang, Y. (2026). A multi-omics framework integrating gut microbiota, blood metabolites, and immune cells to elucidate the pathogenesis of Alzheimer's disease. Frontiers in immunology, 17, 1842398. https://
BibTeX
@article{wang2026multi,
author = {Wang, Bei and Yan, Wei and Zhang, Yusheng},
title = {{A multi-omics framework integrating gut microbiota, blood metabolites, and immune cells to elucidate the pathogenesis of Alzheimer's disease}},
journal = {Frontiers in immunology},
year = {2026},
month = jul,
volume = {17},
pages = {1842398},
publisher = {Frontiers Media SA},
issn = {1664-3224},
doi = {10.3389/
url = {https://
pmid = {42519311},
pmcid = {PMC13381253}
}
RIS
TY - JOUR
AU - Wang, Bei
AU - Yan, Wei
AU - Zhang, Yusheng
TI - A multi-omics framework integrating gut microbiota, blood metabolites, and immune cells to elucidate the pathogenesis of Alzheimer's disease
T2 - Frontiers in immunology
J2 - Front Immunol
PY - 2026
DA - 2026/
VL - 17
SP - 1842398
SN - 1664-3224
PB - Frontiers Media SA
DO - 10.3389/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.3389/
"type": "article-journal",
"title": "A multi-omics framework integrating gut microbiota, blood metabolites, and immune cells to elucidate the pathogenesis of Alzheimer's disease",
"container-title": "Frontiers in immunology",
"author": [
{
"family": "Wang",
"given": "Bei"
},
{
"family": "Yan",
"given": "Wei"
},
{
"family": "Zhang",
"given": "Yusheng"
}
],
"container-title-short":
"volume": "17",
"page": "1842398",
"DOI": "10.3389/
"PMID": "42519311",
"PMCID": "PMC13381253",
"ISSN": "1664-3224",
"publisher": "Frontiers Media SA",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
7,
6
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1002/alz.71680
- A combined artificial intelligence-wet lab approach identifies a pivotal role of the NAD&
lt;sup& gt;+& lt;/ sup& gt;-mitophagy axis on aging and neurodegeneration. Journal: Alzheimer's & dementia : the journal of the Alzheimer's AssociationIn common: NCBI GEO GSE36980, Alzheimer's / dementia, cellular / molecular - [2] doi:10.3389/fnmol.2023.1150399
- GAP-43 closely interacts with BDNF in hippocampal neurons and is associated with Alzheimer's disease progression.Journal: Frontiers in molecular neuroscienceIn common: NCBI GEO GSE36980, Alzheimer's / dementia, cellular / molecular
- [3] doi:10.1016/j.bbih.2022.100546
- Miltefosine as a PPM1A activator improves AD-like pathology in mice by alleviating tauopathy via microglia/
neurons crosstalk. Journal: Brain, behavior, & immunity - healthIn common: NCBI GEO GSE36980, Alzheimer's / dementia, cellular / molecular - [4] doi:10.1007/s11011-023-01171-0 [code]
- Bioinformatics investigation on blood-based gene expressions of Alzheimer's disease revealed ORAI2 gene biomarker susceptibility: An explainable artificial intelligence-based approach.Journal: Metabolic brain diseaseIn common: NCBI GEO GSE36980, Alzheimer's / dementia
- [5] doi:10.3390/ijms23116223
- Physical Activity Rewires the Human Brain against Neurodegeneration.Journal: International journal of molecular sciencesIn common: NCBI GEO GSE36980, Alzheimer's / dementia
- [6] doi:10.1126/sciadv.adz3323 [code]
- Silencer variants are key drivers of gene up-regulation in Alzheimer's disease.Journal: Science advancesIn common: Alzheimer's / dementia, cellular / molecular, 3 references
- [7] doi:10.1016/j.tjpad.2025.100422
- Systematic post-translational modification genome wide identifies therapeutic targets for Alzheimer's disease: evidence from multi-cohort analysis.Journal: The journal of prevention of Alzheimer's diseaseIn common: Alzheimer's / dementia, genetics / omics, 2 references
- [8] doi:10.3390/biom16040570
- Variecolactone, a Natural PDE4 Inhibitor from Marine-Derived &
lt;i& gt;Talaromyces& lt;/ i& gt; sp. ZSD-1, Alleviates Amyloid-β Accumulation and mtDNA Dyshomeostasis via cAMP-PKA-CREB Signaling Pathway. Journal: BiomoleculesIn common: Alzheimer's / dementia, cellular / molecular, 2 references - [9] doi:10.1186/s40168-026-02342-8 [code]
- Impacts of host genetics on gut microbiome composition in Alzheimer's disease.Journal: MicrobiomeIn common: Alzheimer's / dementia, genetics / omics, 2 references
- [10] doi:10.1186/s40364-025-00851-6 [code]
- Immune, blood-brain barrier, and metabolic biomarkers mediate gut-brain axis crosstalk in alzheimer's disease.Journal: Biomarker researchIn common: Alzheimer's / dementia, genetics / omics, 2 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.